Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 48,300 shares at $28.50 ($1.4M) on 2026-01-09, disclosed to the SEC on 2026-01-13.
Scheduled sale ($1.4M) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.98 | 48,057 | $1.3M | 99.5% |
| 2 | $28.50 | 243 | $7K | 0.5% |
| Total | $27.98 avg | 48,300 | $1.4M | 100% |
| Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |
| ELVN | SELL | 2025-08-11 | $236K | — | Filing → |